CN Patent

CN110831606A — 治疗帕金森氏病(pd)和相关疾病的组合物和方法

Assigned to Finch Research and Development LLC · Expires 2020-02-21 · 6y expired

What this patent protects

本公开属于适于治疗哺乳动物疾病的药物组合物领域。本公开提供了用于治疗PD和相关疾病的包含非致病粪便微生物或无菌粪便滤液的新型组合物。本公开还提供了用本文公开的组合物治疗受试者的方法。

USPTO Abstract

本公开属于适于治疗哺乳动物疾病的药物组合物领域。本公开提供了用于治疗PD和相关疾病的包含非致病粪便微生物或无菌粪便滤液的新型组合物。本公开还提供了用本文公开的组合物治疗受试者的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN110831606A
Jurisdiction
CN
Classification
—
Expires
2020-02-21
Drug substance claim
No
Drug product claim
No
Assignee
Finch Research and Development LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.